Literature DB >> 22739013

Comparison of implant quality between loose and intra-operatively linked iodine-125 seeds in prostate cancer brachytherapy.

Laimonas Jarusevicius1, Arturas Inciura, Elona Juozaityte, Kestutis Vaiciunas, Antanas Vaitkus, Migle Sniureviciute.   

Abstract

From 2007 to 2010, 230 patients had iodine-125 seeds implanted (loose or intra-operatively linked into seed trains with variable seed-to-seed spacing). The primary aim was to evaluate differences in implant quality by comparing the intra-operative and post-implant dosimetry in patients treated with loose and intra-operatively linked seeds. The secondary aim was to evaluate the "learning curve" for the procedure. The following parameters were compared: the radiation dose to 90% of the prostate volume (D90), the radiation dose to 30% of the urethral volume (DU30), the percentage of the prostate volume receiving 100% or 200% of the prescribed dose (V100 or V200, respectively), the percentage of the rectal volume receiving 100% of the prescribed dose (VR100), and the homogeneity index (HI). We obtained the following results for loose vs. intra-operatively linked seeds: D90 (Gy), 184.7 ± 15.0 vs. 177.9 ± 12.7 (p = 0.002); V100 (%), 95.5 ± 2.4 vs. 94.9 ± 3.2 (p = 0.206); V200 (%), 35.1 ± 7.5 vs. 24.3 plusmn; 6,9 (p < 0.001); DU30 (Gy), 218.6 ± 24.1 vs. 197.4 ± 19.5 (p = 0.001); VR100 (cm³), 0.6 ± 0.47 vs. 0.3 ± 0.3 (p < 0.001); HI (%), 31.8 ± 7.3 vs. 44.0 ± 9.8 (p < 0.001). The advantages of intra-operatively linked seed implantation over loose seed implantation are a more homogeneous prostate dose and lower urethral and rectal doses. The disadvantage is a lower post-implant D90. Sufficient experience with the loose seed implantation procedure was obtained after the first 40 patients. There was essentially no learning curve when a new implantation method using intra-operatively linked seeds was subsequently initiated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22739013     DOI: 10.1269/jrr.11064

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  12 in total

1.  A dosimetry method for low dose rate brachytherapy by EGS5 combined with regression to reflect source strength shortage.

Authors:  Kenichi Tanaka; Kunihiko Tateoka; Osamu Asanuma; Ken-Ichi Kamo; Kaori Sato; Hiromitsu Takeda; Masaru Takagi; Masato Hareyama; Jun Takada
Journal:  J Radiat Res       Date:  2014-01-20       Impact factor: 2.724

2.  Strength estimation of a moving 125Iodine source during implantation in brachytherapy: application to linked sources.

Authors:  Kenichi Tanaka; Satoru Endo; Kunihiko Tateoka; Osamu Asanuma; Masakazu Hori; Masaru Takagi; Gerard Bengua; Ken-Ichi Kamo; Kaori Sato; Hiromitsu Takeda; Masato Hareyama; Koh-Ichi Sakata; Jun Takada
Journal:  J Radiat Res       Date:  2014-07-01       Impact factor: 2.724

3.  An in vitro verification of strength estimation for moving an 125I source during implantation in brachytherapy.

Authors:  Kenichi Tanaka; Tsuyoshi Kajimoto; Takahiro Hayashi; Osamu Asanuma; Masakazu Hori; Ken-Ichi Kamo; Iori Sumida; Yutaka Takahashi; Kunihiko Tateoka; Gerard Bengua; Koh-Ichi Sakata; Satoru Endo
Journal:  J Radiat Res       Date:  2018-07-01       Impact factor: 2.724

4.  Plan reproducibility of intraoperatively custom-built linked seeds compared to loose seeds for prostate brachytherapy.

Authors:  Tomoya Kaneda; Toshio Ohashi; Masanori Sakayori; Shinya Sutani; Shoji Yamashita; Tetsuo Momma; Shinichi Takahashi; Takashi Hanada; Naoyuki Shigematsu
Journal:  J Contemp Brachytherapy       Date:  2018-08-31

5.  Measurement of the strength of iodine-125 seed moving at unknown speed during implantation in brachytherapy.

Authors:  Kenichi Tanaka; Satoru Endo; Kunihiko Tateoka; Osamu Asanuma; Ken-Ichi Kamo; Kaori Sato; Hiromitsu Takeda; Masaru Takagi; Masato Hareyama; Jun Takada
Journal:  J Radiat Res       Date:  2013-06-30       Impact factor: 2.724

6.  Effects of iodine-125 seeds on the methylation of SFRP2 and P16 in colorectal cancer.

Authors:  Xiaogang Li; Ping Lu; Bo Li; Wangfu Zhang; Kaiyuan Luo
Journal:  Exp Ther Med       Date:  2013-09-13       Impact factor: 2.447

7.  Iodine-125 induces apoptosis via regulating p53, microvessel density, and vascular endothelial growth factor in colorectal cancer.

Authors:  Zhenhuan Ma; Yong Yang; Guokai Yang; Jia Wan; Guojian Li; Ping Lu; Lingjuan Du
Journal:  World J Surg Oncol       Date:  2014-07-17       Impact factor: 2.754

8.  Comparison of implant quality between intraoperatively built custom-linked seeds and loose seeds in permanent prostate brachytherapy using sector analysis.

Authors:  Norihisa Katayama; Mitsuhiro Takemoto; Atsushi Takamoto; Hiroki Ihara; Kuniaki Katsui; Shin Ebara; Yasutomo Nasu; Susumu Kanazawa
Journal:  J Radiat Res       Date:  2016-03-13       Impact factor: 2.724

9.  Dosimetry advantages of intraoperatively built custom-linked seeds compared with loose seeds in permanent prostate brachytherapy.

Authors:  Masahiro Inada; Masaki Yokokawa; Takafumi Minami; Kiyoshi Nakamatsu; Yasumasa Nishimura
Journal:  J Contemp Brachytherapy       Date:  2017-10-19

10.  Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy.

Authors:  Katsumi Hirose; Masahiko Aoki; Mariko Sato; Hiroyoshi Akimoto; Yasuhiro Hashimoto; Atsushi Imai; Noritaka Kamimura; Hideo Kawaguchi; Yoshiomi Hatayama; Ichitaro Fujioka; Mitsuki Tanaka; Chikara Ohyama; Yoshihiro Takai
Journal:  Radiat Oncol       Date:  2017-12-01       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.